Company Filing History:
1 out of 2,489 
1 out of 269 
Years Active: 1994
Title: Donna M Anderson: Innovator in Bioassay Technology
Introduction
Donna M Anderson is a notable inventor based in Muttenz, Switzerland. She has made significant contributions to the field of bioassay technology, particularly through her innovative work involving monoclonal antibodies. Her research has implications for the quantitative assessment of biologically active ligands, which are crucial in various medical applications.
Latest Patents
Donna M Anderson holds a patent for a sensitive bioassay that utilizes monoclonal antibodies to bind to specific ligands. This invention provides a quantitative assay for determining the amount of biologically active ligands, such as human chorionic gonadotropin and luteinizing hormone, present in a sample. The method involves contacting the sample with both the receptor to which the ligand naturally binds and a monoclonal antibody directed to the ligand or to a complex of the ligand and receptor. This innovative approach allows for the formation of a complex that can be quantitatively analyzed, providing valuable information for biological activity assessments. The patent also includes the development of kits for quantitatively assaying the presence of these biologically active ligands or their corresponding receptors.
Career Highlights
Throughout her career, Donna M Anderson has worked with prestigious institutions, including Columbia University and the University of Medicine and Dentistry of New Jersey. Her work has been instrumental in advancing the understanding and application of bioassays in medical research and diagnostics.
Collaborations
Donna has collaborated with notable colleagues, including Robert E Canfield and E Glenn Armstrong. These partnerships have contributed to the development and refinement of her innovative bioassay technologies.
Conclusion
Donna M Anderson's contributions to the field of bioassay technology highlight her role as a pioneering inventor. Her work continues to influence medical diagnostics and research, showcasing the importance of innovation in the scientific community.